Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stipo Jurcevic

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Current Opinion in Nephrology and Hypertension|October 18, 2003
Gene microarrays in transplantationStipo Jurcevic, Steven Sacks
Trends in Molecular Medicine|April 23, 2004
Selective depletion of activated T cells: the CD40L-specific antibody experienceRoseanna E G Hargreaves, Nicola J Monk, Stipo Jurcevic
Plos One|March 4, 2014
FRA2 is a STAT5 target gene regulated by IL-2 in human CD4 T cellsAradhana Rani, Roseanna Greenlaw, Manohursingh Runglall, et al.
British Journal of Clinical Pharmacology|July 18, 2015
The effect of a selective CXCR2 antagonist (AZD5069) on human blood neutrophil count and innate immune functionsStipo Jurcevic, Charles Humfrey, Mohib Uddin, et al.
Drug Design, Development and Therapy|January 19, 2017
Effects of multiple-dose ponesimod, a selective S1P<sub>1</sub> receptor modulator, on lymphocyte subsets in healthy humansStipo Jurcevic, Pierre-Eric Juif, Colleen Hamid, et al.
Clinical Therapeutics|March 18, 2008
Two single-center, double-blind, randomized, placebo-controlled, phase I studies to investigate the tolerability and pharmacokinetics of CH-1504, an antifolate, in healthy male subjectsTim Mant, Stipo Jurcevic, Cameron Szakacs, et al.
International Immunopharmacology|August 9, 2011
Effects of a cytokine inhibitor, JTE-607, on the response to endotoxin in healthy human volunteersSvetlana Borozdenkova, Timothy G K Mant, Elizabeth Allen, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 28, 2006
Transplant tolerance: models, concepts and factsNicola J Monk, Roseanna E G Hargreaves, Elizabeth Simpson, et al.
Transplantation|June 24, 2010
Intermittent antibody-based combination therapy removes alloantibodies and achieves indefinite heart transplant survival in presensitized recipientsHina Shariff, Yakup Tanriver, Kathryn L Brown, et al.
International Journal of Molecular Sciences|February 15, 2022
microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma CellsMaria Mortoglou, Francesc Miralles, Elif Damla Arisan, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Opinion in Nephrology and Hypertension|October 18, 2003
Gene microarrays in transplantationStipo Jurcevic, Steven Sacks
Trends in Molecular Medicine|April 23, 2004
Selective depletion of activated T cells: the CD40L-specific antibody experienceRoseanna E G Hargreaves, Nicola J Monk, Stipo Jurcevic
Plos One|March 4, 2014
FRA2 is a STAT5 target gene regulated by IL-2 in human CD4 T cellsAradhana Rani, Roseanna Greenlaw, Manohursingh Runglall, et al.
British Journal of Clinical Pharmacology|July 18, 2015
The effect of a selective CXCR2 antagonist (AZD5069) on human blood neutrophil count and innate immune functionsStipo Jurcevic, Charles Humfrey, Mohib Uddin, et al.
Drug Design, Development and Therapy|January 19, 2017
Effects of multiple-dose ponesimod, a selective S1P<sub>1</sub> receptor modulator, on lymphocyte subsets in healthy humansStipo Jurcevic, Pierre-Eric Juif, Colleen Hamid, et al.
Clinical Therapeutics|March 18, 2008
Two single-center, double-blind, randomized, placebo-controlled, phase I studies to investigate the tolerability and pharmacokinetics of CH-1504, an antifolate, in healthy male subjectsTim Mant, Stipo Jurcevic, Cameron Szakacs, et al.
International Immunopharmacology|August 9, 2011
Effects of a cytokine inhibitor, JTE-607, on the response to endotoxin in healthy human volunteersSvetlana Borozdenkova, Timothy G K Mant, Elizabeth Allen, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 28, 2006
Transplant tolerance: models, concepts and factsNicola J Monk, Roseanna E G Hargreaves, Elizabeth Simpson, et al.
Transplantation|June 24, 2010
Intermittent antibody-based combination therapy removes alloantibodies and achieves indefinite heart transplant survival in presensitized recipientsHina Shariff, Yakup Tanriver, Kathryn L Brown, et al.
International Journal of Molecular Sciences|February 15, 2022
microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma CellsMaria Mortoglou, Francesc Miralles, Elif Damla Arisan, et al.
Pageof 3